Cancer Genetics
Why Robinhood?
You can watch CGIX and buy or sell other stocks, ETFs, and their options commission-free!About CGIX
Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning.
CGIX Key Statistics
Stock Snapshot
As of today, Cancer Genetics(CGIX) shares are valued at $4.61. The company's market cap stands at 1.23M, with a P/E ratio of -0.09.
On 2026-04-01, Cancer Genetics(CGIX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Cancer Genetics(CGIX) stock has reached 0, versus its average volume of 45.95K.
The stock's 52-week range extends from a low of $0.14 to a high of $1.58.
The stock's 52-week range extends from a low of $0.14 to a high of $1.58.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.